Daily Small Cap Market News and Stock Highlights from SmallCapVoice.com

U.S. stocks are following overseas markets, which are rising after officials from the Group of 20 countries agreed to keep economic stimulus measures in place.

Investors are awaiting retailers' earnings reports to see how much consumers are spending as the holidays approach. The market is concerned that rising unemployment, which now sits at 10.2 percent, will further discourage already hesitant consumers from spending.

Still, the Labor Department's jobless report Friday hasn't deterred investors, who were buying stocks on the theory that the weak labor market will prompt the Federal Reserve to keep interest rates low for some time.

In early trading, the Dow Jones industrial average rose 81.70, or 0.8 percent, at 10,105.12. The broader Standard & Poor's 500 index rose 9.69, or 0.9 percent, at 1,078.99, and the Nasdaq composite index is up 23.61, or 1.12 percent, at 2,136.05.

Yesterday’s Top Performing Small Cap stock:

GWS Technologies, Inc. (OTC BB: GWSC) was a SmallCapVoice.com top performer yesterday closing up over 6% on trading volume 20,813 of shares.

GWS stands for GreenWindSolar. We are a renewable energy technology company developing and marketing solar and wind-powered renewable energy products and solutions. Our products and solutions are part of the new micro-generation movement that is transforming the way businesses and consumers provide for their energy needs. The company was founded in 2005 and is headquartered in Scottsdale, Arizona.

Today’s SmallCapVoice.com Hot Stock to Watch:

Global Health Ventures Inc. (OTC BB: GHLV)

Global Health Ventures Inc., a Specialty Pharma, announced today that it has completed the prototype manufacturing of the drug "X-Excite" Global's male enhancement drug. The manufacturing of the product was carried out under contract with Vida Pharma of Montreal, Canada. Vida Pharma specialized in the designing of the new tablet size, taste, and hardness.

The Company has manufactured over 4000 pills from several different incipient and coatings that are all safe for human consumption. These various batches will be tested at the University of British Columbia, Canada for independent evaluation in regards to drugs adsorption, taste, color and hardness. If the samples meet our end goals then the drug will be ready for mass production under the proprietary formula for testing in humans and finally applying for regulatory approval.

The Company plans to meet the regulatory bodies in the United States, Canada and Europe to assess the time and length of the human clinical trials in the near future. The X-Excite drug is the Company's lead prescription drug. The Company is hoping to manufacture it so it can be qualified under the OTC (over the counter for pharmaceuticals) Market. If approvals are attained we believe that the product will generate a very lucrative revenue stream for Global Health.

About SmallCapVoice.com

SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide.  Known for its ability to help emerging growth companies build a following among retail and institutional investors, SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its client's financial news releases. SmallCapVoice.com also offers individual investors with all the tools they need to make informed decisions about the stocks they are interested in. Tools like our stock charts, stock alerts, and our investor fact sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets.

Small Cap Voice SCV is an electronic publication, and is for informational purposes only. The stocks profiled by SCV are only company profiles and are not intended to be and should not be accepted by you as recommendations to buy or sell in these securities. These profiles are compiled from publicly available sources. Our sources include, but are not limited to, online research, company profiles, member suggestions, magazines, newspapers, analyst suggestions, broker recommendations, contact with the company, company rumors, press releases and other similar information sources. All profiles are based on information that is accessible by the public. Investing in stocks involves risk. SCV is not and does not hold itself out to be a registered broker or dealer or other licensed securities professional. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles.  For compensation and complete disclaimer click here.

Contact:

Stuart T. Smith

CEO

512-267-2430

ssmith@smallcapvoice.com
http://www.smallcapvoice.com